Partially Covered Metal Stents May Not Prolong Stent Patency Compared to Uncovered Stents in Unresectable Malignant Distal Biliary Obstruction
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Controversy still exists regarding the benefits of covered self-expandable metal stents (SEMSs) compared to uncovered SEMSs. We aimed to compare the patency and stent-related adverse events of partially covered SEMSs (PC-SEMSs) and uncovered SEMSs in unresectable malignant distal biliary obstruction. Methods: A total of 134 patients who received a PC-SEMS or uncovered SEMS for palliation of unresectable malignant distal biliary obstruction were reviewed retrospectively. The main outcome measures were stent patency, stent-related adverse events, and overall survival. Results: The median stent patency was 118 days (range, 3 to 802 days) with PC-SEMSs and 105 days (range, 2 to 485 days) with uncovered SEMSs (p=0.718). The overall endoscopic revision rate due to stent dysfunction was 36.6% (26/71) with PC-SEMSs and 36.5% (23/63) with uncovered SEMSs (p=0.589). Tumor ingrowth was more frequent with uncovered SEMSs (4.2% vs 19.1%, p=0.013), but migration was more frequent with PC-SEMSs (11.2% vs 1.5%, p=0.04). The incidence of stent-related adverse events was 2.8% (2/71) with PC-SEMSs and 9.5% (6/63) with uncovered SEMSs (p=0.224). The median overall survival was 166 days with PC-SEMSs and 168 days with uncovered SEMSs (p=0.189). Conclusions: Compared to uncovered SEMSs, PC-SEMSs did not prolong stent patency in unresectable malignant distal biliary obstruction. Stent migration was more frequent with PC-SEMSs. However, tumor ingrowth was less frequent with PC-SEMSs compared to uncovered SEMSs.
Abstract
Background/Aims: Controversy still exists regarding the benefits of covered self-expandable metal stents (SEMSs) compared to uncovered SEMSs. We aimed to compare the patency and stent-related adverse events of partially covered SEMSs (PC-SEMSs) and uncovered SEMSs in unresectable malignant distal biliary obstruction. Methods: A total of 134 patients who received a PC-SEMS or uncovered SEMS for palliation of unresectable malignant distal biliary obstruction were reviewed retrospectively. The main outcome measures were stent patency, stent-related adverse events, and overall survival. Results: The median stent patency was 118 days (range, 3 to 802 days) with PC-SEMSs and 105 days (range, 2 to 485 days) with uncovered SEMSs (p=0.718). The overall endoscopic revision rate due to stent dysfunction was 36.6% (26/71) with PC-SEMSs and 36.5% (23/63) with uncovered SEMSs (p=0.589). Tumor ingrowth was more frequent with uncovered SEMSs (4.2% vs 19.1%, p=0.013), but migration was more frequent with PC-SEMSs (11.2% vs 1.5%, p=0.04). The incidence of stent-related adverse events was 2.8% (2/71) with PC-SEMSs and 9.5% (6/63) with uncovered SEMSs (p=0.224). The median overall survival was 166 days with PC-SEMSs and 168 days with uncovered SEMSs (p=0.189). Conclusions: Compared to uncovered SEMSs, PC-SEMSs did not prolong stent patency in unresectable malignant distal biliary obstruction. Stent migration was more frequent with PC-SEMSs. However, tumor ingrowth was less frequent with PC-SEMSs compared to uncovered SEMSs.
참고문헌 (28)
- Andersen JR, "Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice", Gut, 30, pp.1132~1135 (1989)
- Smith AC, "Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction", Lancet, 344, pp.1655~1660 (1994)
- Davids PH, "Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction", Lancet, 340, pp.1488~1492 (1992)
- Huibregtse K, "Biliary stent occlusion: a problem solved with self-expanding metal stents? European Wallstent Study Group", Endoscopy, 24, pp.391~394 (1992)
- Knyrim K, "A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct", Endoscopy, 25, pp.207~212 (1993)
- O’Brien S, "A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction", Gut, 36, pp.618~621 (1995)
- Rossi P, "Metallic stents in malignant biliary obstruction: results of a multicenter European study of 240 patients", J Vasc Interv Radiol, 5, pp.279~285 (1994)
- Prat F, "A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct", Gastrointest Endosc, 47, pp.1~7 (1998)
- Walter D, "Cost efficacy of metal stents for palliation of extrahepatic bile duct obstruction in a randomized controlled trial", Gastroenterology, 149, pp.130~138 (2015)
- Saleem A, "Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction", Gastrointest Endosc, 74, pp.321~327.e3 (2011)
- Almadi MA, "No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis", Clin Gastroenterol Hepatol, 11, pp.27~37.e1 (2013)
- Shepherd HA, "Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial", Br J Surg, 75, pp.1166~1168 (1988)
- Dowidar N, "Clogging of biliary endoprostheses: a morphologic and bacteriologic study", Scand J Gastroenterol, 26, pp.1137~1144 (1991)
- Cotton PB, "A lexicon for endoscopic adverse events: report of an ASGE workshop", Gastrointest Endosc, 71, pp.446~454 (2010)
- Kaassis M, "Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study", Gastrointest Endosc, 57, pp.178~182 (2003)
- Isayama H, "A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction", Gut, 53, pp.729~734 (2004)
- Kitano M, "Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial", Am J Gastroenterol, 108, pp.1713~1722 (2013)
- Yoon WJ, "A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction", Gastrointest Endosc, 63, pp.996~1000 (2006)
- Telford JJ, "A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction", Gastrointest Endosc, 72, pp.907~914 (2010)
- Kullman E, "Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study", Gastrointest Endosc, 72, pp.915~923 (2010)
- Speer AG, "Biliary stent blockage with bacterial biofilm: a light and electron microscopy study", Ann Intern Med, 108, pp.546~553 (1988)
- Gillams A, "Self-expandable stainless steel braided endoprosthesis for biliary strictures", Radiology, 174, pp.137~140 (1990)
- Tsang TK, "Inhibition of biliary endoprostheses occlusion by ampicillin-sulbactam in an in vitro model", J Lab Clin Med, 130, pp.643~648 (1997)
- Tsang TK, "Silicone-covered metal stents: an in vitro evaluation for biofilm formation and patency", Dig Dis Sci, 44, pp.1780~1785 (1999)
- Leung JW, "Decreased bacterial adherence to silver-coated stent material: an in vitro study", Gastrointest Endosc, 38, pp.338~340 (1992)
- Sung JJ, "Long-term ciprofloxacin treatment for the prevention of biliary stent blockage: a prospective randomized study", Am J Gastroenterol, 94, pp.3197~3201 (1999)
- Jang SI, "Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: a prospective comparative", Dig Dis Sci, 58, pp.865~871 (2013)
- Song TJ, "Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction: a prospective comparative pilot study", Gastrointest Endosc, 73, pp.727~733 (2011)